There is growing evidence of the diagnostic, prognostic and predictive role of BRAF mutation in colorectal cancer. BRAF mutation, together with MSI and CIMP, is also a key feature of large bowel tumors that develop through the serrated pathway. Aim of this study was to examine the clinical and pathological features associated with BRAF mutated colorectal cancers in relation to microsatellite instability status and to compare in the group of Mismatch Repair proficient (MMR-P) carcinomas the characteristics of BRAF-mutated, KRAS-mutated and KRAS/BRAF-wild type tumors.

Pathologic and molecular features of BRAF mutated colorectal adenocarcinomas

GAFA', Roberta;ULAZZI, Linda;GALLI, Giulia;ZORDAN, Marta;MAESTRI, Iva;LANZA, Giovanni
2016

Abstract

There is growing evidence of the diagnostic, prognostic and predictive role of BRAF mutation in colorectal cancer. BRAF mutation, together with MSI and CIMP, is also a key feature of large bowel tumors that develop through the serrated pathway. Aim of this study was to examine the clinical and pathological features associated with BRAF mutated colorectal cancers in relation to microsatellite instability status and to compare in the group of Mismatch Repair proficient (MMR-P) carcinomas the characteristics of BRAF-mutated, KRAS-mutated and KRAS/BRAF-wild type tumors.
2016
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2365562
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact